Filing Details
- Accession Number:
- 0001209191-13-053228
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-11-19 19:59:41
- Reporting Period:
- 2013-11-14
- Filing Date:
- 2013-11-19
- Accepted Time:
- 2013-11-19 19:59:41
- Original Submission Date:
- 2013-11-18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1463729 | Receptos Inc. | RCPT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575843 | Amir Nashat | 10835 Road To The Cure Suite 205 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-11-14 | 145,582 | $25.00 | 1,041,358 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2013-11-14 | 8,507 | $25.00 | 1,032,851 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2013-11-15 | 14,245 | $24.54 | 1,018,606 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2013-11-15 | 981 | $24.54 | 1,017,625 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 1,040,508.
- The reportable securities are owned directly by Polaris Venture Partners VI, L.P. ("PVP VI"). Polaris Venture Management Co. VI, LLC ("PVM VI") is the general partner of PVP VI. PVM VI disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM VI is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. Dr. Nashat is one of six members of PVM VI, each of whom disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary intent therein.
- (Continued from Footnote 3) The members of North Star Venture Management 2010 LLC are also members of PVM VI, and as members of the general partner, they may be deemed to share voting and investment power over such shares. The principles of North Star Venture Management 2010 LLC disclaim beneficial ownership of such shares, except to the extent of their proportionate pecuniary interest therein.
- The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 1,032,001.
- The reportable securities are owned directly by Polaris Venture Partners Founders' Fund VI, L.P. ("PVPF VI"). PVM VI is the general partner of PVPF VI. PVM VI disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM VI is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. Dr. Nashat is one of six members of PVM VI, each of whom disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein.
- (Continued from Footnote 6) The members of North Star Venture Management 2010 LLC are also members of PVM VI, and as members of the general partner, they may be deemed to share voting and investment power over such shares. The principles of North Star Venture Management 2010 LLC disclaim beneficial ownership of such shares, except to the extent of their proportionate pecuniary interest therein.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $25.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (8) to this Form 4.
- The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 1,017,756.
- The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 1,016,775.